Deep Sequencing Analysis Reveals That KRAS Mutation Is a Marker of Poor Prognosis in Patients with Pulmonary Sarcomatoid Carcinoma.
about
Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept.Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma.The impact of immunohistochemistry on the classification of lung tumors.Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4.Primary Sarcomatoid Carcinoma of the Lung: Radiometabolic ((18)F-FDG PET/CT) Findings and Correlation with Clinico-Pathological and Survival Results.Apatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature review
P2860
Deep Sequencing Analysis Reveals That KRAS Mutation Is a Marker of Poor Prognosis in Patients with Pulmonary Sarcomatoid Carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Deep Sequencing Analysis Revea ...... lmonary Sarcomatoid Carcinoma.
@en
type
label
Deep Sequencing Analysis Revea ...... lmonary Sarcomatoid Carcinoma.
@en
prefLabel
Deep Sequencing Analysis Revea ...... lmonary Sarcomatoid Carcinoma.
@en
P2093
P50
P1476
Deep Sequencing Analysis Revea ...... lmonary Sarcomatoid Carcinoma.
@en
P2093
Carmine Pinto
Cristian Rapicetta
Filippo Lococo
Greta Gandolfi
Massimiliano Paci
P304
P356
10.1016/J.JTHO.2016.04.020
P577
2016-05-05T00:00:00Z